Lakers’ Jeanie Buss ‘contesting’ family’s vote to sell to Kushner, Iger

Jeanie Buss is contesting her siblings’ plan to sell the Lakers’ remaining 17.8% ownership stake to Bob Iger and Josh Kushner, seeking to halt the transaction via alleged trustee-approval requirements tied to maintaining Jeanie’s 15% controlling-owner threshold. The broader Lakers sale has already been agreed at $12.5B (record for a US pro sports franchise) but remains pending NBA approval; Walter’s prior $10B sale to Mark Walter is referenced as the setup. Approval is scheduled for the NBA Board of Governors meeting on Sept. 15–16, keeping timelines and close probabilities uncertain.

Analysis

This is primarily a governance and timing event, not a clean valuation catalyst. When control rights are disputed, the economic value of a trophy asset can stay high while the tradable signal gets diluted by legal optionality, which usually favors patience over chasing the first headline. The relevant market read-through is to other scarce sports/IP owners: if the transaction ultimately clears, it reinforces that irreplaceable live-sports assets still command premium private-market multiples, a modest positive for public comparables like MSGS and TKO.

Near term, the biggest risk is delay into the September approval window or a court-ordered rerun of the ownership vote. That would not just slow the closing; it would increase the discount rate on future bids for similar assets because buyers will demand more certainty around governance and consents. If the buyer group’s reputational/legal overhang becomes central, the market may also question how transferable these record multiples are to other franchises with weaker brand power.

The contrarian point is that the crowd will likely overread the raw price as a universal signal for sports asset inflation. The better interpretation is that scarcity plus clean governance gets paid; assets with messy capital structures, minority blocking rights, or league approval risk do not automatically benefit. Over 1-3 months, a clean approval can lift sentiment in sports-ownership proxies; over 6-18 months, the bigger effect is on the bid/ask for future team sales rather than on operating earnings.

Key Decisions for Investors

• Long MSGS into the September NBA approval window; target a 5-8% re-rating if the sale clears, and cut if the process is delayed past the board meeting.
• Buy TKO 3-6 month call spreads as a broader scarcity-premium proxy; upside is a modest multiple expansion, with defined downside if the market treats this as a one-off.
• Do not force a trade in FOFA on this headline; the signal is too indirect unless the dispute starts moving public sports-comps or special-situations flows.
• Set a hard alert on court action or NBA Board approval: if approval slips beyond mid-September, fade the sports-scarcity trade and take profits in MSGS/TKO on strength.